Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos Iii: EU funding, projects and partners

On this page · 5 sections→

01EU funding
02Projects
03Works most with
04Fields
05Is this you?

Where the EU money came from

Funding by EU programme. Amounts are Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos Iii's own share of each project, not the project's full budget.

FP7 (2007 to 2013)€29.5M · 49 projects
Horizon 2020€19.0M · 27 projects
Horizon Europe€11.1M · 23 projects
Digital Europe Programme (DIGITAL)€1.1M · 1 project
EU4Health Programme (EU4H)€371k · 3 projects

Projects

103 EU-funded projects, newest first. Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos Iii led 41 of them as coordinator. Each links to the official record.

FutureMINDPartner
Training Europe’s Future Leaders in AI-driven Neuro-Oncology Diagnostics and Discovery
Horizon Europe · 2027–2030 · Project on CORDIS ↗
€282ktheir share
MDK_MINIBINDERSCoordinator
Validation of artificial intelligence-based minibinders and inhibitors of Midkine in immune resistant tumours
Horizon Europe · 2026–2028 · Project on CORDIS ↗
€150ktheir share
iN-KEYPartner
iNK Cell–Driven Strategies for Enhanced Multiple Myeloma ImmunotherapY
Horizon Europe · 2026–2031 · Project on CORDIS ↗
€375ktheir share
ADIPOhealthCoordinator
Deciphering the role of adipose tissue in cardiac health and disease: ADIPOhealth
Horizon Europe · 2026–2032 · Project on CORDIS ↗
€3.3Mtheir share
PROPANTHERACoordinator
Retrograde atrophy induction: a paradigm shift in prostate and pancreatic cancer prevention and therapy.
Horizon Europe · 2026–2029 · Project on CORDIS ↗
€573ktheir share
SPARCPartner
Support of Personalized medicine Approaches in Cancer
EU4Health Programme (EU4H) · 2025–2028 · Project on the EU portal ↗
€282ktheir share
JA PCMAssociated partner
Joint Action Personalised Cancer Medicine
EU4Health Programme (EU4H) · 2025–2029 · Project on the EU portal ↗
€14ktheir share
PERIFORMANCEPartner
PUBLIC ENGAGEMENT IN RESEARCH INFRASTRUCTURES FOR MISSION CANCER: MANAGING COMPLEXITY OF EMERGING TECHNOLOGIES
Horizon Europe · 2025–2028 · Project on CORDIS ↗
€320ktheir share
Intra-RANKLCoordinator
Targeting intracelular RANKL in breast cancer
Horizon Europe · 2025–2026 · Project on CORDIS ↗
€150ktheir share
MENTORPartner
Metabolic control of cell growth by mTOR in health and disease: a multi-disciplinary training
Horizon Europe · 2025–2028 · Project on CORDIS ↗
€252ktheir share
JANE-2Associated partner
Joint Action on Networks of Expertise on Cancer
EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗
€75ktheir share
GoEPartner
Genome of Europe
Digital Europe Programme (DIGITAL) · 2024–2028 · Project on the EU portal ↗
€1.1Mtheir share
WAC-mTOR-OCCoordinator
Targeting R2TP/TTT/WAC/mTOR complex in ovarian cancer.
Horizon Europe · 2024–2027 · Project on CORDIS ↗
€186ktheir share
NutFLirsFACoordinator
NUTRIENT FLUCTUATIONS AND THE INTEGRATIVE STRESS RESPONSE AS METABOLIC CELL FATE DETERMINANTS IN B CELL LYMPHOMA
Horizon Europe · 2024–2026 · Project on CORDIS ↗
€165ktheir share
HD-BRECACoordinator
Integrating longitudinal multi-modal profiling of metastatic breast cancer patients for high-definition oncology
Horizon Europe · 2024–2026 · Project on CORDIS ↗
€165ktheir share
NIGHTMADRIDPartner
Researchers and citizen creating together a better future
Horizon Europe · 2024–2026 · Project on CORDIS ↗
€7ktheir share
INN-TIMECoordinator
Co-option of host circadian rhythms in cancer
Horizon Europe · 2024–2029 · Project on CORDIS ↗
€1.5Mtheir share
EvolveBBMRIPartner
Accelerating datafication for support of EU health priorities, greening of biobanks and integrated approach to “One Health”
Horizon Europe · 2024–2026 · Project on CORDIS ↗
€161ktheir share
GUIDE.MRDPartner
GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€1.3Mtheir share
TargetRANKCoordinator
Targeting RANK receptor as a novel therapeutic strategy in triple negative breast cancer
Horizon Europe · 2023–2024 · Project on CORDIS ↗
€150ktheir share
CohesiNetPartner
Cohesin and its regulators: from chromosome dynamics and nuclear architecture to human diseases
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€252ktheir share
Maxima ButterflyAssociated partner
From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network
Horizon Europe · 2023–2027 · Project on CORDIS ↗
PANCAIDPartner
PANcreatic CAncer Initial Detection via liquid biopsy
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€864ktheir share
RepliFateAssociated partner
DNA replication at the heart of cell fate decisions and cancer development
Horizon Europe · 2022–2026 · Project on CORDIS ↗
EOSC4CancerPartner
A European-wide foundation to accelerate Data-driven Cancer Research
Horizon Europe · 2022–2025 · Project on CORDIS ↗
€191ktheir share
REACTPartner
Respiratory Host-Pathogen Interaction
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€802ktheir share
MADRIDNIGHTPartner
Researchers and citizens: facing together the European challenges
Horizon Europe · 2022–2024 · Project on CORDIS ↗
€5ktheir share
MAtChinGCoordinator
Mechanically Activated Channels in Glioma: the role of mechanoreceptor Piezo1 and hnRNP K in cancer as novel oncoregulators
Horizon 2020 · 2021–2023 · Project on CORDIS ↗
€161ktheir share
TARGETSETCoordinator
Commercial feasibility of targeting the histone methyltransferase SETD8 in cancer: New chemical entities and biomarkers.
Horizon 2020 · 2021–2022 · Project on CORDIS ↗
€150ktheir share
PANCAIMPartner
Pancreatic cancer AI for genomics and personalized Medicine
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€842ktheir share
P70-IMMUNEBREASTCoordinator
Tumor compartment-specific effects of P70S6K in early triple negative breast cancer: regulation of antitumor immune response and therapeutic implications
Horizon 2020 · 2021–2023 · Project on CORDIS ↗
€161ktheir share
METALERT-STOPCoordinator
Imaging, characterizing and targeting metastatic niches in melanoma
Horizon 2020 · 2020–2027 · Project on CORDIS ↗
€2.5Mtheir share
PDASwITchCoordinator
Super-enhancer modules controlling plasticity and response to therapy in pancreatic cancer
Horizon 2020 · 2020–2022 · Project on CORDIS ↗
€161ktheir share
ALTER-brainCoordinator
Metastasis-associated altered molecular patterns in the brain
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
€1.9Mtheir share
SHELTERINSCoordinator
Targeting Shelterin Proteins in Cancer
Horizon 2020 · 2020–2026 · Project on CORDIS ↗
€2.5Mtheir share
proEVLifeCyclePartner
The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
€251ktheir share
TranSYSPartner
Translational SYStemics: Personalised Medicine at the Interface of Translational Research and Systems Medicine
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€251ktheir share
NanoBRIGHTPartner
BRInGing nano-pHoTonics into the brain
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€713ktheir share
EPIC-XSPartner
European Proteomics Infrastructure Consortium providing Access
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
€481ktheir share
METLINKCoordinator
METLINK: Identification of links between cancer cell growth and metabolism genes.
Horizon 2020 · 2018–2020 · Project on CORDIS ↗
€158ktheir share

Show 40 more projects

CSI-FunPartner
Chronic Systemic Inflammation: Functional organ cross-talk in inflammatory disease and cancer
Horizon 2020 · 2018–2024 · Project on CORDIS ↗
METMELCoordinator
Long range-acting drivers of premetastatic niches in melanoma
Horizon 2020 · 2017–2021 · Project on CORDIS ↗
€170ktheir share
THERACANCoordinator
Novel therapeutic strategies to treat pancreatic and lung cancer
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
€2.5Mtheir share
DLL4-LVNCoordinator
Targeting the (pre)metastatic lympho-vascular niche: molecular mechanisms and therapeutic implications in melanoma
Horizon 2020 · 2017–2018 · Project on CORDIS ↗
€158ktheir share
PLEIO-RANKCoordinator
Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity
Horizon 2020 · 2016–2023 · Project on CORDIS ↗
€1.2Mtheir share
NoCanTherPartner
Nanomedicine upscaling for early clinical phases of multimodal cancer therapy
Horizon 2020 · 2016–2021 · Project on CORDIS ↗
€89ktheir share
NutrientSensingVivoCoordinator
The Physiology of Nutrient Sensing by mTOR
Horizon 2020 · 2016–2021 · Project on CORDIS ↗
€1.8Mtheir share
IMMUTRAINPartner
Training Network for the Immunotherapy of Cancer
Horizon 2020 · 2015–2019 · Project on CORDIS ↗
€496ktheir share
TOPOmicsCoordinator
Global dynamics of topoisomerase-induced DNA breaks
Horizon 2020 · 2015–2021 · Project on CORDIS ↗
€259ktheir share
CELLPLASTICITYPartner
New Frontiers in Cellular Reprogramming: Exploiting Cellular Plasticity
Horizon 2020 · 2015–2021 · Project on CORDIS ↗
€465ktheir share
AVATARPartner
Integrating Genomics and Avatar Mouse Models to Personalize Pancreatic Cancer Treatment
Horizon 2020 · 2015–2020 · Project on CORDIS ↗
€501ktheir share
BRIDGESPartner
Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES)
Horizon 2020 · 2015–2021 · Project on CORDIS ↗
€859ktheir share
OpenMinTeDPartner
Open Mining INfrastructure for TExt and Data
Horizon 2020 · 2015–2018 · Project on CORDIS ↗
€147ktheir share
GLIDDCoordinator
DNA Damage Response (DDR) signaling in tumor formation and therapeutic resistance of gliomas
FP7 (2007 to 2013) · 2014–2018 · Project on CORDIS ↗
€100ktheir share
RSHEALTHCoordinator
Investigating the causes and consequences of replication stress in mammalian health
FP7 (2007 to 2013) · 2014–2020 · Project on CORDIS ↗
€2.0Mtheir share
CAM-PACPartner
Integrative Analysis of Gene Functions in Cellular and Animal Models of Pancreatic Cancer
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€778their share
TRANSBIOBCPartner
Translation of novel Biomarkers for Bladder Cancer for clinical outcome prediction
FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗
€549ktheir share
PERSMEDOMICSCoordinator
Bioinformatics and Integrative Genomics for a Novel Personalized Cancer Therapy
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
€100ktheir share
KIBindingPartner
Improving the selectivity of kinase inhibitors: Characterizing binding mechanisms of inhibitors targeting inactive states and allosteric sites
FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗
RD-CONNECTPartner
RD-CONNECT: An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research
FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗
€407ktheir share
RISK - IRPartner
Risk, Stem Cells and Tissue Kinetics – Ionising Radiation
FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
€399ktheir share
ADDRESSPartner
Joint training and research network on Chromatin Dynamics and the DNA Damage Response
FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗
€235ktheir share
Mastl CDCCoordinator
Role of the protein kinase Mastl in Cell Division and Cancer
FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗
€227ktheir share
PanClonCoordinator
Clonal analysis in pancreatic development, differentiation and carcinogenesis
FP7 (2007 to 2013) · 2011–2013 · Project on CORDIS ↗
€231ktheir share
BLUEPRINTPartner
A BLUEPRINT of Haematopoietic Epigenomes
FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗
€671ktheir share
SMARTBREAKERCoordinator
Rational designing of new meganucleases as molecular scissors for genomic tailoring
FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗
€75ktheir share
MULTIFUNPartner
Multifunctional Nanotechnology for selective detection and Treatment of cancer
FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗
€446ktheir share
DMONICKASEDESIGNCoordinator
Safer gene repair and targeting based on the monomeric meganuclease I-DmoI by design of homologous-recombination-inducing nickase activity
FP7 (2007 to 2013) · 2011–2013 · Project on CORDIS ↗
€155ktheir share
CANCERALIACoordinator
Development of novel diagnostic and therapeutic approaches to improve patient outcome in lung and pancreatic tumours
FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗
€1.6Mtheir share
OPEN PHACTSPartner
The Open Pharmacological Concepts Triple Store
FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗
€390ktheir share
EPC-TM-NETPartner
Targeting the tumour microenvironment to improve pancreatic cancer prognosis
FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗
€550ktheir share
ENS@T-CANCERPartner
European Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adults
FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗
€484ktheir share
EUROBATSPartner
Identifying biomarkers of ageing using whole transcriptomic sequencing
FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗
€381ktheir share
LUNGTARGETPartner
New approaches for the targeted therapy of Non-Small Cell Lung Cancer
FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗
€259ktheir share
EUROCANPLATFORMPartner
A European Platform for Translational Cancer Research
FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗
€198ktheir share
ASSETPartner
ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours
FP7 (2007 to 2013) · 2010–2016 · Project on CORDIS ↗
€420ktheir share
MITOSYSPartner
Systems Biology of Mitosis
FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗
€526ktheir share
RAS AHEADCoordinator
Ras Genes in Health and Disease
FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗
€2.5Mtheir share
INFLAIDCANCoordinator
The role of activation-induced cytidine deaminase in inflammation-induced carcinogenesis
FP7 (2007 to 2013) · 2010–2011 · Project on CORDIS ↗
€162ktheir share
ETOXPartner
Integrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicities
FP7 (2007 to 2013) · 2010–2016 · Project on CORDIS ↗
€400ktheir share

Showing the 80 most recent of 103 projects.

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

DNA
RNA
agriculture
alkaline earth metals
amines
artificial intelligence
autoimmune diseases
biological interactions
biomolecules
biophysics
bladder cancer
breast cancer
business models
carbohydrates

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗